AI assistant
Bliss GVS Pharma Limited Major Shareholding Notification 2021
61284_rns_2021-05-19_6e41778a-5708-4d38-bc91-9b5344266170.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
POLUS GLOBAL FUND
(Company No.: C110931 C1/GBL)
Date: 17 May 2021
Bombay Stock Exchange Limited (BSE) P J Towers, Dalal Street, Mumbai-400 001
By Email: [email protected]
Sub: Intimation/Disclosures under SEBI (SAST) Regulations, 2011 - Bliss GVS Pharma Limited
Dear Sir/Madam,
Please find enclosed a declaration in the prescribed format for the sale of Equity of Bliss GVS Pharma Limited on 17 May 2021 in due compliance with regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeover) Regulations, 2011.
We kindly request to update your records accordingly.
Your Faithfully, For and on the behalf of Polus Global Fund
$10ba$ $\mathcal{C}_{\rho}$ Vidvotma LOTUN Director
Encs.
POLUS GLOBAL FUND
Format for disclosures under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and
Takeovers) Regulations. 2011
| Name of the Target Company (TC) | BLISS GVS PHARMA LIMITED | ||
|---|---|---|---|
| Name(s) of the acquirer and Persons Acting in Concert (PAC) with the acquirer |
POLUS GLOBAL FUND | ||
| Whether the acquirer belongs to Promoter/Promoter group | NON-PROMOTER | ||
| Name(s) of the Stock Exchange(s) where the shares of TC are Listed |
BSE Limited (BSE) and National Stock Exchange of India Ltd (NSE) |
||
| Details of the acquisition / disposal as follows | Number | % w.r.t. total share/voting capital wherever $applicable(*)$ |
% w.r.t. total diluted share/voting capital of the TC $(**)$ |
| Before the acquisition/disposal under consideration, holding of: | |||
| a) Shares carrying voting rights b) Shares in the nature of encumbrance (pledge/lien/ non-disposal undertaking/others) c) Voting rights (VR) otherwise than by equity shares d) Warrants/convertible securities/any other instrument that entitles the acquirer to receive shares carrying voting rights in the TC (specify holding in each category) Total $(a+b+c+d)$ e) |
5,281,025 0 $\boldsymbol{0}$ $\boldsymbol{0}$ 5,281,025 |
5.1199 $\boldsymbol{0}$ $\boldsymbol{0}$ $\boldsymbol{0}$ 5.1199 |
5.1199 $\mathbf{0}$ $\mathbf{0}$ $\mathbf{0}$ 5.1199 |
| Details of acquisition/sale: | |||
| a) Shares carrying voting rights acquired/sold b) VRs acquired/sold otherwise than by equity shares c) Warrants/convertible securities/any other instrument that entitles the acquirer to receive shares carrying voting rights in the TC (specify holding in each |
506,025 $\theta$ $\boldsymbol{0}$ |
0.4906 $\theta$ $\boldsymbol{0}$ |
0.4906 0 $\boldsymbol{0}$ |
$\mathbb{I}$
$\mathbb{I}$
Ĭ
Ĩ
Ĩ
POLUS GLOBAL FUND
| category) acquired/sold d) Shares encumbered/invoked/released by the acquirer e) Total $(a+b+c+/-d)$ |
$\mathbf{0}$ 506,025 |
$\mathbf{0}$ 0.4906 |
$\theta$ 0.4906 |
|
|---|---|---|---|---|
| After the acquisition/sale, holding of: | ||||
| a) Shares carrying voting rights b) Shares encumbered with the acquirer c) VRs otherwise than by shares d) Warrants/convertible securities/any other instrument that entitles the acquirer to receive shares carrying voting rights in the TC (specify holding in each category) after acquisition e) Total $(a+b+c+d)$ |
4,775,000 0 $\theta$ $\mathbf{0}$ 4,775,000 |
4.6293 $\boldsymbol{0}$ $\theta$ $\mathbf{0}$ 4.6293 |
4.6293 $\boldsymbol{0}$ 0 $\boldsymbol{0}$ 4.6293 |
|
| Mode of acquisition / sale (e.g. open market / off market / public issue / rights issue / preferentialallotment/inter-se transfer/encumbrance, etc.) |
OPEN MARKET (IN NSE AND BSE) | |||
| Date of acquisition / sale of shares / VR or date of receipt- of intimation of allotment of whichever is applicable |
17 MAY 2021 | |||
| Equity share capital / total voting capital of the TC before the said acquisition / sale |
103,146,672 | |||
| Equity share capital/total voting capital of the TC after the said acquisition / sale |
103,146,672 | |||
| Total diluted share/voting capital of the TC after the said acquisition / sale |
103,146,672 |
(*) Total share capital/voting capital to be taken as per the latest filing done by the company to the Stock Exchange under Clause 35 of the listing Agreement.
(**) Diluted share/voting capital means the total number of shares in the TC assuming full conversion of the outstanding convertible securities/warrants into equity shares of the TC.
For and on behalf of POLUS GLOBAL FUND
******
Company No.: C110931 C1/GBL Suite 305, 3rd Floor NG Tower, Ebene Cybercity, Republic of Mauritius. Tel: +230 466 0381/466 1885 Fax: +230 466 3264 Email: [email protected]